BR0110943A - Derivados de dissulfeto úteis para o tratamento de doenças alérgicas - Google Patents

Derivados de dissulfeto úteis para o tratamento de doenças alérgicas

Info

Publication number
BR0110943A
BR0110943A BR0110943-0A BR0110943A BR0110943A BR 0110943 A BR0110943 A BR 0110943A BR 0110943 A BR0110943 A BR 0110943A BR 0110943 A BR0110943 A BR 0110943A
Authority
BR
Brazil
Prior art keywords
treatment
disulfide derivatives
allergic diseases
derivatives useful
useful
Prior art date
Application number
BR0110943-0A
Other languages
English (en)
Inventor
Zixia Feng
Mark R Hellberg
Steven T Miller
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BR0110943A publication Critical patent/BR0110943A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43—Y being a hetero atom
    • C07C323/44—X or Y being nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"DERIVADOS DE DISSULFETO úTEIS PARA O TRATAMENTO DE DOENçAS ALéRGICAS". A presente invenção refere-se aos derivados de dissulfeto de difenila de fórmula (I) em que X é -NHC(=O)NH-R e R é como definido nas reivindicações são úteis para tratar ou prevenir doenças alérgicas do olho, do nariz, da pele, da orelha, do trato gastrointestinal, das vias aéreas ou do pulmão e prevenir ou tratar manifestações de mastocistose sistêmica. Os derivados de dissulfeto atuam como estabilizadores de mastócito.
BR0110943-0A 2000-05-19 2001-04-25 Derivados de dissulfeto úteis para o tratamento de doenças alérgicas BR0110943A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20582700P 2000-05-19 2000-05-19
PCT/US2001/013331 WO2001090060A1 (en) 2000-05-19 2001-04-25 Disulfide derivatives useful for treating allergic diseases

Publications (1)

Publication Number Publication Date
BR0110943A true BR0110943A (pt) 2004-01-06

Family

ID=22763799

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110943-0A BR0110943A (pt) 2000-05-19 2001-04-25 Derivados de dissulfeto úteis para o tratamento de doenças alérgicas

Country Status (20)

Country Link
US (3) US6492552B2 (pt)
EP (1) EP1282599B1 (pt)
JP (1) JP2003534318A (pt)
KR (1) KR20030007589A (pt)
CN (2) CN1241912C (pt)
AR (1) AR028566A1 (pt)
AT (1) ATE330938T1 (pt)
AU (2) AU2001255675B2 (pt)
BR (1) BR0110943A (pt)
CA (1) CA2407964A1 (pt)
CY (1) CY1105164T1 (pt)
DE (1) DE60120961T2 (pt)
DK (1) DK1282599T3 (pt)
ES (1) ES2261402T3 (pt)
HK (1) HK1050185A1 (pt)
MX (1) MXPA02011481A (pt)
PL (1) PL365457A1 (pt)
PT (1) PT1282599E (pt)
WO (1) WO2001090060A1 (pt)
ZA (1) ZA200208840B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0110845A (pt) * 2000-05-19 2003-02-11 Alcon Inc Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas
AU2003259007A1 (en) 2002-10-31 2004-05-25 Amersham Biosciences Ab Use of urea variants as affinity ligands
AU2005259911A1 (en) * 2004-06-28 2006-01-12 Alcon, Inc. Topical formulations for treating allergic diseases
EP1841808B1 (en) * 2004-12-22 2009-01-21 California Institute Of Technology Degradable p0lymers and methods of preparation thereof
EP2720712B1 (en) * 2011-06-17 2016-03-02 Halozyme, Inc. Stable formulations of a hyaluronan-degrading enzyme
US20130011378A1 (en) 2011-06-17 2013-01-10 Tzung-Horng Yang Stable formulations of a hyaluronan-degrading enzyme
FR3057264B1 (fr) 2016-10-12 2020-05-29 Arkema France Composes porteurs de groupes associatifs azotes
CN108586299B (zh) * 2018-06-06 2020-06-16 北京化工大学 一种可引发、聚合及降低体积收缩的芳香二硫化合物的制备方法及用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (pt) 1967-08-08 1971-05-19
US3663616A (en) 1969-10-13 1972-05-16 Sherwin Williams Co Bis(2-carbamylphenyl)disulfides
DE2967337D1 (en) * 1978-06-16 1985-02-07 Kyowa Hakko Kogyo Kk Antithrombotic pharmaceutical preparation containing 2,2'-dithiobis benzamide derivatives and new 2,2'-dithiobis benzamide derivatives
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9020933D0 (en) 1990-09-26 1990-11-07 Ici Plc Compound,preparation and use
US5859017A (en) 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US5463122A (en) 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
JPH095926A (ja) * 1995-04-18 1997-01-10 Fuji Photo Film Co Ltd 熱現像感光材料
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US6225327B1 (en) 1996-04-18 2001-05-01 Alcon Laboratories, Inc. Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
JP2894445B2 (ja) 1997-02-12 1999-05-24 日本たばこ産業株式会社 Ｃｅｔｐ活性阻害剤として有効な化合物
JP3940201B2 (ja) 1997-05-20 2007-07-04 大塚製薬株式会社 ３，３’−ジチオジベンゾヒドロキサム酸

Also Published As

Publication number Publication date
AU5567501A (en) 2001-12-03
MXPA02011481A (es) 2003-06-06
EP1282599A1 (en) 2003-02-12
ES2261402T3 (es) 2006-11-16
CN1616422A (zh) 2005-05-18
DE60120961D1 (de) 2006-08-03
PT1282599E (pt) 2006-08-31
AR028566A1 (es) 2003-05-14
CY1105164T1 (el) 2010-03-03
CN1429209A (zh) 2003-07-09
US6506802B2 (en) 2003-01-14
US6500864B1 (en) 2002-12-31
EP1282599B1 (en) 2006-06-21
DK1282599T3 (da) 2006-07-31
WO2001090060A1 (en) 2001-11-29
ZA200208840B (en) 2003-12-02
CN1175807C (zh) 2004-11-17
US20020193633A1 (en) 2002-12-19
US6492552B2 (en) 2002-12-10
US20020193634A1 (en) 2002-12-19
CN1241912C (zh) 2006-02-15
US20020058709A1 (en) 2002-05-16
AU2001255675B2 (en) 2005-04-14
ATE330938T1 (de) 2006-07-15
DE60120961T2 (de) 2006-11-16
CA2407964A1 (en) 2001-11-29
HK1050185A1 (en) 2003-06-13
KR20030007589A (ko) 2003-01-23
PL365457A1 (en) 2005-01-10
JP2003534318A (ja) 2003-11-18

Similar Documents

Publication Publication Date Title
BR0314319A (pt) Transferência de gene mediada por vetor lentiviral e usos da mesma
CY1112444T1 (el) Χρηση των παραγωγων σουλφαμιδιου βενζο-συντηγμενου ετεροκυκλου ως νευροπροστατευτικοι παραγοντες
BR0310100A (pt) métodos para tratar, prevenir ou reduzir a lesão de reperfusão isquêmica em um tecido ou órgão, e para prevenir ou tratar de uma condição associada com a privação de oxigênio, seguida por suprimento de oxigênio aumentado a um tecido ou órgão em necessidade disto
BR9914109A (pt) Composições antibióticas para tratamento dos olhos, ouvidos e nariz
CY1105164T1 (el) Παραγωγα δισουλφιδιου χρησιμα για θepαπεια αλλepγικων ασθενειων
RS51790B (en) USE OF BENZO-CONDENSED HETEROCYCLIC SULFAMIDES DERIVATIVES FOR MANIA AND BIPOLAR DISORDER TREATMENT
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
MXPA04000647A (es) Acido 5-aminolevulinico y sus esteres, en combinacion con otro fotosensibilizador, como agentes fotosensibilizadores en fotoquimioterapia y sus usos en el tratamiento de heridas.
NO20050718L (no) Topikal behandling av hudsykdommer
BR0316776A (pt) Formula para anti-infeccioso tópico
BR0309623A (pt) Agentes que regulam. inibem ou modulam a atividade e/ou a expressão do fator de crescimento de tecido conjuntivo (ctgf) como um único meio de diminuir a pressão intraocular e tratar retinopatias glaucomatosas/neuropatias ópticas
BR0207316A (pt) Derivados de epotilona para o tratamento de tumores refratários
BR0016172A (pt) 4-piridinil-n-acil-l-fenilalaninas
BR9714677A (pt) "enantiÈmeros 3-piridila e seu uso como analgésicos"
BR0107628A (pt) l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial
AU2101800A (en) Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
BR0110845A (pt) Derivados de dissulfeto de anilina para o tratamento de doenças alérgicas
BR0213479A (pt) Utilização do irbesartan para a preparação de medicamentos úteis para a prevenção ou o tratamento da hipertensão pulmonar
BR0110852A (pt) Composições que contêm um derivado dissulfeto de benzamida para tratamento de doenças alérgicas
BR0004813A (pt) Constructos vesiculares marcados para citoproteção e tratamento de infecções por h. pylori
ATE429919T1 (de) Prophylaktische und therapeutische verwendung von hydroxysteroiden
CN109200095A (zh) 一种治疗胃炎的中药
BR0205625C1 (pt) Formulações nasais em gel
TW200744582A (en) Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009.